EDIT:NASDAQ
Editas Medicine Inc
၂.၁၇ US$
arrow_upward
+၁.၄၀%(+၀.၀၃၀) 1D
နို ၁၃, GMT-၅ ၁၆:၀၀:၀၁ · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EDIT...
Open
၂.၁၄ US$
High
၂.၂၁ US$
Low
၂.၀၁ US$
Mkt. cap
၃၃.၄၉ ကုဋေ
Avg. vol.
၂.၄၂ သန်း
Volume
၂.၇၉ သန်း
52-wk high
၃.၉၄ US$
52-wk low
၁.၆၆ US$
EPS
-၀.၆၂ US$
Beta
၂.၀၉
Shares outstanding
၁၅.၄၃ ကုဋေ
No. of employees
၈၇
Open
၂.၁၄ US$
High
၂.၂၁ US$
Low
၂.၀၁ US$
Mkt. cap
၃၃.၄၉ ကုဋေ
Avg. vol.
၂.၄၂ သန်း
Volume
၂.၇၉ သန်း
52-wk high
၃.၉၄ US$
52-wk low
၁.၆၆ US$
EPS
-၀.၆၂ US$
Beta
၂.၀၉
Shares outstanding
၁၅.၄၃ ကုဋေ
No. of employees
၈၇
News stories
From web sources and news partners
Benzinga
·
ပြီးခဲ့သည့် ၃၅ မိနစ်
Dow Jones, Nasdaq 100, and S&P 500 Outlooks: Key Stock Market News This Week
BigGo Finance
·
ပြီးခဲ့သည့် ၈ နာရီ
Goldman Sachs Sets 8,700 S&P 500 Target for 2027, Sees 14% Upside as AI Capex Peaks
The Motley Fool
·
ပြီးခဲ့သည့် ၂ နာရီ
This Dividend King Yields 5 Times the S&P 500. Is It a Buy Now?
Traders Union
·
ပြီးခဲ့သည့် ၅ နာရီ
Chris Ciovacco: Semiconductors SMH and S&P 500 SPY show several possible support areas
Profile
Editas Medicine, Inc., is a clinical-stage biotechnology company that is developing therapies for rare diseases using CRISPR gene editing technology. Editas Medicine headquarters is located in Cambridge, Massachusetts with additional facilities in Boulder, Colorado. Wikipedia
About Editas Medicine Inc